Search results for "Estradiol"

showing 10 items of 203 documents

Ontogeny of gonadotropin releasing hormone and gonadotropin immunoreactivity in brain and pituitary of normal and estrogen-treated guppies, Poecilia …

1987

Gonadotropin releasing hormone (GnRH) and gonadotropic hormone (GTH) were identified by immunohistochemistry in the brains and pituitaries of neonate, juvenile and adult guppies. GTH was present in some cells of the pars intermedia (pi) and proximal pars distalis (ppd) of all animals. GnRH was found in the perikarya of the nucleus olfactoretinalis. In the pituitaries of juvenile 30-day-old guppies, GnRH-immunoreactive cells existed in a "juvenile pattern", whereas in adult animals GnRH was recognized in only a few cells. GnRH-immunoreactive fibers were seen in the pituitaries of animals that were 30 days or older. In adult guppies, the ventral and lateral ppd (the gonadotropic region) conta…

endocrine systemPituitary glandmedicine.medical_specialtyAgingHistologymedicine.drug_classGonadotropin-releasing hormonePeptide hormoneBiologyGonadotropic cellEthinyl EstradiolPathology and Forensic MedicineGonadotropin-Releasing HormoneImmunoenzyme TechniquesCyprinodontiformesInternal medicinemedicineJuvenileAnimalsPoeciliaHistocytochemistryBrainPars intermediaCell BiologyLuteinizing Hormonemedicine.anatomical_structureEndocrinologyPituitary GlandFemaleGonadotropinLuteinizing hormonehormones hormone substitutes and hormone antagonistsGonadotropinsCell and tissue research
researchProduct

Effects of LHRH, progesterone, estradiol-17 ? and dexamethasone in vitro on pineal synaptic ribbons and serotonin N-acetyltransferase activity in die…

1991

Pineal glands of regularly cycling Sprague Dawley rats (180-220 g) killed on the diestrous morning (between 0900-1000 h) were incubated in appropriate media for six hours with LHRH (8.5 microM), progesterone (3.2 microM), estradiol-17 beta (370 nM) or dexamethasone (250 nM). Pineals incubated in hormone-free medium and unincubated glands served as controls. Six rats were used in each group. After incubation the glands were divided into two parts. One part was used to estimate serotonin N-acetyltransferase (NAT) activity. The other part was processed for electron microscopy to quantify synaptic ribbons (SR). The SR numbers were computed to 20,000 microns 2 area of pineal tissue. The number a…

endocrine systemmedicine.medical_specialtyArylamine N-AcetyltransferaseGonadotropin-releasing hormoneBiologyPineal GlandDexamethasonePinealocyteGonadotropin-Releasing HormonePineal glandEstrusInternal medicinemedicineAnimalsProgesteroneBiological PsychiatryDexamethasoneOrganellesEstrous cycleSynaptic ribbonEstradiolRats Inbred StrainsRatsPsychiatry and Mental healthmedicine.anatomical_structureEndocrinologyNeurologyFemaleNeurology (clinical)Serotoninhormones hormone substitutes and hormone antagonistsmedicine.drugEndocrine glandJournal of Neural Transmission
researchProduct

Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome

2008

BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) typically occurs when ovaries are primed with FSH/ LH and subsequently exposed to hCG. The ultimate pathophysiological step underlying this clinical picture is increased vascular permeability (VP). METHODS: A search of the literature was carried out using PubMed and the authors’ files. RESULTS: In rodents and humans, the expression of vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR-2) mRNA increases during ovarian stimulation. With the administration of hCG, the expression of each rises to a maximum. Expression of VEGF/VEGFR-2 mRNAs correlates with enhanced VP, with both peaking 48 h following an injection of hCG. Imm…

endocrine systemmedicine.medical_specialtyCabergolineIndolesOvarian hyperstimulation syndromeVascular permeabilityBiologyChorionic GonadotropinDopamine agonistCapillary PermeabilityOvarian Hyperstimulation Syndromechemistry.chemical_compoundInternal medicineCabergolinemedicineAnimalsHumansPyrrolesErgolinesPhosphorylationCells CulturedClinical Trials as TopicEstradiolVascular Endothelial Growth FactorsObstetrics and GynecologyEstrogensKinase insert domain receptormedicine.diseaseRatsVascular endothelial growth factorActin CytoskeletonVascular endothelial growth factor Amedicine.anatomical_structureEndocrinologyReproductive MedicinechemistryDopamine AgonistsReproductive Control AgentsFemaleCorpus luteumSignal Transductionmedicine.drugHuman Reproduction Update
researchProduct

In vitro effects of estradiol, testosterone, and progesterone on 5-methoxyindole content, cyclic adenosine 3',5'-monophosphate synthesis, and norepin…

1986

To examine the effects of estradiol, testosterone, or progesterone on cyclic adenosine 3',5'-monophosphate (AMP) accumulation, 5-methoxyindole levels, and norepinephrine (NE) release by the female guinea pig pineal complex, samples of the deep, intermediate, or superficial portions of the complex were incubated in vitro with varied concentrations of either hormone. Exposure for 10 minutes to physiological amounts of estradiol (10 nM) or to 100 microM NE increased significantly cyclic AMP levels to the same extent in the three pineal regions. A maximal effect on cyclic AMP accumulation was observed at 100-nM concentrations of estradiol, with a tendency to return to basal levels at 1-10 micro…

endocrine systemmedicine.medical_specialtyIndolesGuinea PigsStimulationBiologyIn Vitro TechniquesPineal GlandNorepinephrine (medication)Guinea pigMelatoninNorepinephrineEndocrinologyPostsynaptic potentialInternal medicinemedicineCyclic AMPAnimalsTestosteroneGonadal Steroid HormonesTestosteroneProgesteroneEstradiolHydroxyindoleacetic AcidAdenosineEndocrinologyFemalehormones hormone substitutes and hormone antagonistsmedicine.drugHormoneJournal of pineal research
researchProduct

The non-aromatizable androgen dihydrotestosterone (DHT) facilitates sexual behavior in ovariectomized female rats primed with estradiol

2020

Abstract It is still unclear whether Testosterone (T) increases sexual desire through a stimulation of the androgen receptor in relevant brain regions or through its conversion to estrogens. The aim of this study was to clarify the mechanisms of T facilitation of female sexual desire by assessing the effect of a non-aromatizable androgen (Dihydrotestosterone, DHT) in a validated animal model. Ovariectomized (OVX) Long-Evans rats were treated with oil (O) + O, 10 mcg Estradiol Benzoate (EB) + O, 10 mcg EB + 500 mcg Progesterone (P), O + 500 mcg DHT or 10 mcg EB + 500 mcg DHT (n = 12 per group). EB was administered 48 h, while P and DHT 4 h, prior to 4 sexual behavioral testing sessions in bi…

endocrine systemmedicine.medical_specialtyLordosismedicine.drug_classEndocrinology Diabetes and MetabolismOvariectomyReceptivitySolicitationSettore BIO/09 - Fisiologia03 medical and health scienceschemistry.chemical_compoundSexual Behavior Animal0302 clinical medicineEndocrinologyInternal medicineSexual desiremedicineAnimalsRats Long-EvansBiological PsychiatryTestosteroneProgesteroneEstradiolEndocrine and Autonomic SystemsChemistryEstrogensDihydrotestosteroneAndrogenmedicine.diseasePreclinical030227 psychiatryRatsAndrogen receptorPsychiatry and Mental healthEndocrinologyDihydrotestosteroneOvariectomized ratEstradiol benzoateAndrogenssexual behavior female ratRatFemaleProgestinshormones hormone substitutes and hormone antagonists030217 neurology & neurosurgerymedicine.drug
researchProduct

Increased LH and FSH release from the anterior pituitary of ovariectomized rat, in vivo, by copper-, nickel-, and zinc-LHRH complexes.

1992

Abstract The effect of Cu 2+ , Ni 2+ , Zn 2+ and their complexes with LHRH on the release of luteinizing hormone (LH) and follicle stimulating hormone (FSH) was estimated in in vivo experiments with the use of the method proposed by Ramirez and McCann. Ovariectomized, estradiol, and progesterone pretreated rats were injected intraveneously either with LHRH alone, a metal ion alone, a mixture of metal and hormone, or a metal-LHRH complex. A metal alone or a mixture of it with LHRH did not affect gonadotropin release at all or no more than LHRH alone. However, the complex of Cu 2+ with LHRH brought about a high release of LH and even higher release of FSH. This indicates that copper complex i…

endocrine systemmedicine.medical_specialtymedicine.drug_classOvariectomyPeptide hormoneBiochemistryInorganic ChemistryGonadotropin-Releasing HormoneFollicle-stimulating hormoneAnterior pituitaryIn vivoNickelPituitary Gland AnteriorInternal medicinemedicineAnimalsProgesteroneEstradiolChemistryRats Inbred StrainsLuteinizing HormoneRatsZincmedicine.anatomical_structureEndocrinologyMetalsOvariectomized ratFemaleGonadotropinFollicle Stimulating HormoneLuteinizing hormonehormones hormone substitutes and hormone antagonistsCopperHormoneJournal of inorganic biochemistry
researchProduct

Estrogen Receptor and Vascular Aging.

2021

Cardiovascular diseases remain an age-related pathology in both men and women. These pathologies are 3-fold more frequent in men than in women before menopause, although this difference progressively decreases after menopause. The vasculoprotective role of estrogens are well established before menopause, but the consequences of their abrupt decline on the cardiovascular risk at menopause remain debated. In this review, we will attempt to summarize the main clinical and experimental studies reporting the protective effects of estrogens against cardiovascular diseases, with a particular focus on atherosclerosis, and the impact of aging and estrogen deprivation on their endothelial actions. Th…

endotheliumvascular agingGeriatricsestradiolRC952-954.6menopauseGeneral Medicineatherosclerosisestrogen receptorFrontiers in aging
researchProduct

Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases

2013

Obesity is associated with aberrant sodium/potassium-ATPase (Na+/K+-ATPase) activity, apparently linked to hyperglycemic hyperinsulinemia, which may repress or inactivate the enzyme. The reduction of Na+/K+-ATPase activity in cardiac tissue induces myocyte death and cardiac dysfunction, leading to the development of myocardial dilation in animal models; this has also been documented in patients with heart failure (HF). During several pathological situations (cardiac insufficiency and HF) and in experimental models (obesity), the heart becomes more sensitive to the effect of cardiac glycosides, due to a decrease in Na+/K+-ATPase levels. The primary female sex steroid estradiol has long been …

estradiol sodium/potassium adenosine triphosphatase obesity cardiovascular diseases
researchProduct

Hormonikorvaushoito ja luurankolihaksisto : estrogeenisten ja progestogeenisten komponenttien vaikutukset lihassoluviljelmässä

2010

Yksi merkittävimmistä ikääntymiseen liittyvistä tapahtumista on luurankolihasten heikentyminen. Sarkopenia eli lihaskato heikentää ennen kaikkea ikääntyvän ihmisen terveyttä ja sitä kautta elämänlaatua, mutta sen kustannukset myös sosiaali- ja terveydenhuollolle ovat suuret. Naisilla lihasten suorituskyky heikkenee merkittävästi vaihdevuosien aikana, jolloin myös estrogeenin ja progesteronin tasot laskevat. Etenkin 17β-estradiolin (E2) tuotanto munasarjoissa loppuu vaihdevuosien aikana. Estrogeenin tiedetään vaikuttavan primaaristen sukupuoliominaisuuksien lisäksi myös moniin muihin kudoksiin, kuten luuhun ja lihaksiin. Vaihdevuosien mukanaan tuomia oireita hoidetaan usein estradiolia ja pr…

estradioliAktmTORhormonihoitosarkopenianoretisteroniasetaattilihakset
researchProduct

Effects of combined hormone replacement therapy or its effective agents on the IGF-1 pathway in skeletal muscle.

2010

Objectives To investigate the effects of combined hormone replacement therapy (HRT) and its effective agents on the IGF-1 signaling pathway. Design and methods To examine the effects of HRT on skeletal muscle in vivo, we utilized pre- and post-intervention samples from a randomized double blinded trial with 50–57-year-old women. The intervention included the year-long use of either HRT preparation (2 mg 17β-estradiol, E2; 1 mg norethisterone acetate, NETA, n = 10) or placebo (CO, n = 9). Microarray technology and quantitative PCR (qPCR) were used to study the expression of insulin-like growth factor I (IGF-1) and its splice variants as well as IGF-1 receptor, Akt1, mTOR, FOXO1, FOXO3, atrog…

estradioliTranscription GeneticEndocrinology Diabetes and MetabolismMuscle Fibers SkeletalEstrogen receptorpostmenopausal womenMuscle ProteinsFOXO1Receptor IGF Type 10302 clinical medicineEndocrinologyProtein IsoformsTestosteroneInsulin-Like Growth Factor IReceptorRandomized Controlled Trials as Topic0303 health sciencesEstradiolMyogenesisForkhead Box Protein O1TOR Serine-Threonine KinasesEstrogen Replacement TherapyForkhead Box Protein O3Forkhead Transcription FactorsMiddle Agedmedicine.anatomical_structureReceptors EstrogenReceptors AndrogenFemalemedicine.medical_specialtynorethisterone acetate030209 endocrinology & metabolismBiologypostmenopausaalinen nainen03 medical and health sciencesInternal medicinemedicineHumansnoretisteroniasetaattiluurankolihasskeletal muscleMuscle SkeletalProtein kinase BPI3K/AKT/mTOR pathway030304 developmental biologyhormonikorvaushoitoSKP Cullin F-Box Protein LigasesSkeletal muscleAndrogen receptorNorethindrone AcetateEndocrinologyHormone replacement therapyIGF-1 signalointiNorethindroneIGF-1 signalingProto-Oncogene Proteins c-aktGrowth hormoneIGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
researchProduct